Exome Sequencing–Based Screening for BRCA1/2 Expected Pathogenic Variants Among Adult Biobank Participants
Kandamurugu Manickam, MD, MPH1,2; Adam H. Buchanan, MS, MPH2; Marci L. B. Schwartz, ScM2; et alMiranda L. G. Hallquist, MSc2; Janet L. Williams, MS2; Alanna Kulchak Rahm, PhD, MS2; Heather Rocha, MS2; Juliann M. Savatt, MS2; Alyson E. Evans, BS2; Loren M. Butry, MS2; Amanda L. Lazzeri, BS2; D’Andra M. Lindbuchler, MSN2; Carroll N. Flansburg, MPH2; Rosemary Leeming, MD, MHCM2; Victor G. Vogel, MD, MHS2; Matthew S. Lebo, PhD3; Heather M. Mason-Suares, PhD3; Derick C. Hoskinson, PhD3; Noura S. Abul-Husn, MD, PhD4; Frederick E. Dewey, MD4; John D. Overton, PhD4; Jeffrey G. Reid, PhD4; Aris Baras, MD4; Huntington F. Willard, PhD2; Cara Z. McCormick, MPH2; Sarath B. Krishnamurthy, PhD2; Dustin N. Hartzel, BS2; Korey A. Kost, BS2; Daniel R. Lavage, BS2; Amy C. Sturm, MS2; Lauren R. Frisbie, BS2; T. Nate Person, MS2; Raghu P. Metpally, PhD2; Monica A. Giovanni, MS2; Lacy E. Lowry, MD2; Joseph B. Leader, BA2; Marylyn D. Ritchie, PhD2,5; David J. Carey, PhD2; Anne E. Justice, PhD2; H. Lester Kirchner, PhD2; W. Andrew Faucett, MS2; Marc S. Williams, MD2; David H. Ledbetter, PhD2; Michael F. Murray, MD2,6
JAMA Network Open. 2018;1(5):e182140. doi:10.1001/jamanetworkopen.2018.2140
No hay comentarios:
Publicar un comentario